TY  - CONF

T1  - Sustained long-term dupilumab efficacy in adult patients with moderate-to-severe atopic dermatitis transitioning from weekly dosing to every other week: Results from an open-label extension trial

JO  - CLINICAL AND EXPERIMENTAL ALLERGY

PY  - 2022/01/01

AU  - Cork MJ

AU  - Beck LA

AU  - Deleuran M

AU  - Hong HC-H

AU  - Adam DN

AU  - Hussain I

AU  - Zhang H

AU  - Shabbir A

AU  - Rodriguez Marco A

AU  - Levit NA

ED  - 

VL  - 52

IS  - 8

SP  - 1014

EP  - 1014

Y2  - 2024/12/22

ER  -